{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:53Z","timestamp":1791977633021,"version":"4.4.0"},"reference-count":52,"publisher":"Japanese Association for Laboratory Animal Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2022]]},"DOI":"10.1538\/expanim.22-0011","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T22:09:51Z","timestamp":1652738991000},"page":"399-410","source":"Crossref","is-referenced-by-count":9,"title":["Calcium carbonate supplementation causes motor dysfunction"],"prefix":"10.1538","volume":"71","author":[{"given":"Ami","family":"Sugiura","sequence":"first","affiliation":[{"name":"College of Environmental Technology, Muroran Institute of Technology, 27-1 Mizumoto, Muroran, Hokkaido 050-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Kitamura","sequence":"additional","affiliation":[{"name":"College of Environmental Technology, Muroran Institute of Technology, 27-1 Mizumoto, Muroran, Hokkaido 050-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"College of Environmental Technology, Muroran Institute of Technology, 27-1 Mizumoto, Muroran, Hokkaido 050-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Popugaeva E, Pchitskaya E, Bezprozvanny I. Dysregulation of intracellular calcium signaling in Alzheimer\u2019s disease. Antioxid Redox Signal.  2018;  29: 1176\u20131188.","DOI":"10.1089\/ars.2018.7506"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Neher E, Sakaba T. Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron.  2008;  59: 861\u2013872.","DOI":"10.1016\/j.neuron.2008.08.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zucker RS. Calcium- and activity-dependent synaptic plasticity. Curr Opin Neurobiol.  1999;  9: 305\u2013313.","DOI":"10.1016\/S0959-4388(99)80045-2"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Berridge MJ. Neuronal calcium signaling. Neuron.  1998;  21: 13\u201326.","DOI":"10.1016\/S0896-6273(00)80510-3"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Szydlowska K, Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium.  2010;  47: 122\u2013129.","DOI":"10.1016\/j.ceca.2010.01.003"},{"key":"6","unstructured":"6. Wieloch T, Siesj\u00f6 BK. Ischemic brain injury: the importance of calcium, lipolytic activities, and free fatty acids. Pathol Biol (Paris).  1982;  30: 269\u2013277."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Z\u00fcndorf G, Reiser G. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal.  2011;  14: 1275\u20131288.","DOI":"10.1089\/ars.2010.3359"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yu JT, Chang RCC, Tan L. Calcium dysregulation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities. Prog Neurobiol.  2009;  89: 240\u2013255.","DOI":"10.1016\/j.pneurobio.2009.07.009"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer\u2019s disease: minding the store. Aging Cell.  2007;  6: 307\u2013317.","DOI":"10.1111\/j.1474-9726.2007.00295.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bojarski L, Herms J, Kuznicki J. Calcium dysregulation in Alzheimer\u2019s disease. Neurochem Int.  2008;  52: 621\u2013633.","DOI":"10.1016\/j.neuint.2007.10.002"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Supnet C, Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium.  2010;  47: 183\u2013189.","DOI":"10.1016\/j.ceca.2009.12.014"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Schapira AH, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson\u2019s disease and Huntington\u2019s disease: future therapeutic perspectives. Lancet.  2014;  384: 545\u2013555.","DOI":"10.1016\/S0140-6736(14)61010-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Verma M, Wills Z, Chu CT. Excitatory dendritic mitochondrial calcium toxicity: Implications for Parkinson\u2019s and other neurodegenerative diseases. Front Neurosci.  2018;  12: 523.","DOI":"10.3389\/fnins.2018.00523"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hasegawa Y, Inoue T, Fuji T. Calcium carbonate supplementation causes memory impairment in mice. Asian Pac J Trop Med.  2018;  11: 576\u2013582.","DOI":"10.4103\/1995-7645.244522"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet.  2015;  386: 896\u2013912.","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sulzer D, Edwards RH. The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s Disease. J Neurochem.  2019;  150: 475\u2013486.","DOI":"10.1111\/jnc.14810"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fayyad M, Salim S, Majbour N, Erskine D, Stoops E, Mollenhauer B, et al.\u3000Parkinson\u2019s disease biomarkers based on \u03b1-synuclein. J Neurochem.  2019;  150: 626\u2013636.","DOI":"10.1111\/jnc.14809"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Singh A, Verma P, Balaji G, Samantaray S, Mohanakumar KP. Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neurochem Int.  2016;  99: 221\u2013232.","DOI":"10.1016\/j.neuint.2016.07.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wang QM, Xu YY, Liu S, Ma ZG. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice. Oncotarget.  2017;  8: 47284\u201347295.","DOI":"10.18632\/oncotarget.17618"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Han JY, Choi TS, Kim HI. Molecular role of Ca<sup>2+<\/sup> and hard divalent metal cations on accelerated fibrillation and interfibrillar aggregation of \u03b1-synuclein. Sci Rep.  2018;  8: 1895.","DOI":"10.1038\/s41598-018-20320-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Chen H, O\u2019Reilly E, McCullough ML, Rodriguez C, Schwarzschild MA, Calle EE, et al.\u3000Consumption of dairy products and risk of Parkinson\u2019s disease. Am J Epidemiol.  2007;  165: 998\u20131006.","DOI":"10.1093\/aje\/kwk089"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chen H, Zhang SM, Hern\u00e1n MA, Willett WC, Ascherio A. Diet and Parkinson\u2019s disease: a potential role of dairy products in men. Ann Neurol.  2002;  52: 793\u2013801.","DOI":"10.1002\/ana.10381"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park M, Ross GW, Petrovitch H, White LR, Masaki KH, Nelson JS, et al.\u3000Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology.  2005;  64: 1047\u20131051.","DOI":"10.1212\/01.WNL.0000154532.98495.BF"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lichtman AH, Clinton SK, Iiyama K, Connelly PW, Libby P, Cybulsky MI. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol.  1999;  19: 1938\u20131944.","DOI":"10.1161\/01.ATV.19.8.1938"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hasegawa Y, Inoue T, Kawaminami S, Fujita M. Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity. Asian Pac J Trop Med.  2016;  9: 662\u2013667.","DOI":"10.1016\/j.apjtm.2016.05.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Liu X, Liu W, Wang C, Chen Y, Liu P, Hayashi T, et al.\u3000Silibinin attenuates motor dysfunction in a mouse model of Parkinson\u2019s disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy. Physiol Behav.  2021;  239: 113510.","DOI":"10.1016\/j.physbeh.2021.113510"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. De Benedetto GE, Fico D, Pennetta A, Malitesta C, Nicolardi G, Lofrumento DD, et al.\u3000A rapid and simple method for the determination of 3,4-dihydroxyphenylacetic acid, norepinephrine, dopamine, and serotonin in mouse brain homogenate by HPLC with fluorimetric detection. J Pharm Biomed Anal.  2014;  98: 266\u2013270.","DOI":"10.1016\/j.jpba.2014.05.039"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Papakonstantinou E, Flatt WP, Huth PJ, Harris RBS. High dietary calcium reduces body fat content, digestibility of fat, and serum vitamin D in rats. Obes Res.  2003;  11: 387\u2013394.","DOI":"10.1038\/oby.2003.52"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Schober A. Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res.  2004;  318: 215\u2013224.","DOI":"10.1007\/s00441-004-0938-y"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Colpaert FC. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat. Neuropharmacology.  1987;  26: 1431\u20131440.","DOI":"10.1016\/0028-3908(87)90110-9"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Wang S, Hu LF, Yang Y, Ding JH, Hu G. Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson\u2019s disease: implications for treating Parkinson\u2019s disease? Neuropharmacology.  2005;  48: 984\u2013992.","DOI":"10.1016\/j.neuropharm.2005.01.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Liu W, Li Y, Jalewa J, Saunders-Wood T, Li L, H\u00f6lscher C. Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson\u2019s disease. Eur J Pharmacol.  2015;  765: 284\u2013290.","DOI":"10.1016\/j.ejphar.2015.08.038"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Haga H, Matsuo K, Yabuki Y, Zhang C, Han F, Fukunaga K. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson\u2019s disease. Neurochem Int.  2019;  129: 104492.","DOI":"10.1016\/j.neuint.2019.104492"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ferro MM, Bellissimo MI, Anselmo-Franci JA, Angellucci MEM, Canteras NS, Da Cunha C. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson\u2019s disease: histological, neurochemical, motor and memory alterations. J Neurosci Methods.  2005;  148: 78\u201387.","DOI":"10.1016\/j.jneumeth.2005.04.005"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kelley AE, Stinus L. Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa. Behav Neurosci.  1985;  99: 531\u2013545.","DOI":"10.1037\/0735-7044.99.3.531"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kim ST, Son HJ, Choi JH, Ji IJ, Hwang O. Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson\u2019s disease. Brain Res.  2010;  1306: 176\u2013183.","DOI":"10.1016\/j.brainres.2009.09.103"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG. Gait dynamics in mouse models of Parkinson\u2019s disease and Huntington\u2019s disease. J Neuroeng Rehabil.  2005;  2: 20.","DOI":"10.1186\/1743-0003-2-20"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Olmstead MC, Franklin KBJ. Lesions of the pedunculopontine tegmental nucleus abolish catalepsy and locomotor depression induced by morphine. Brain Res.  1994;  662: 134\u2013140.","DOI":"10.1016\/0006-8993(94)90805-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Pathania A, Garg P, Sandhir R. Impaired mitochondrial functions and energy metabolism in MPTP-induced Parkinson\u2019s disease: comparison of mice strains and dose regimens. Metab Brain Dis.  2021;  36: 2343\u20132357.","DOI":"10.1007\/s11011-021-00840-2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Lin CH, Wei PC, Chen CM, Huang YT, Lin JL, Lo YS, et al.\u3000Lactulose and melibiose attenuate MPTP-induced Parkinson\u2019s disease in mice by inhibition of oxidative stress, reduction of neuroinflammation and up-regulation of autophagy. Front Aging Neurosci.  2020;  12: 226.","DOI":"10.3389\/fnagi.2020.00226"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gardner B, Dieriks BV, Cameron S, Mendis LHS, Turner C, Faull RLM, et al.\u3000Metal concentrations and distributions in the human olfactory bulb in Parkinson\u2019s disease. Sci Rep.  2017;  7: 10454.","DOI":"10.1038\/s41598-017-10659-6"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Braak H, Del Tredici K, R\u00fcb U, de Vos RAI, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging.  2003;  24: 197\u2013211.","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Yang J, Lv DJ, Li LX, Wang YL, Qi D, Chen J, et al.\u3000Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson\u2019s disease. Neurotoxicology.  2019;  73: 175\u2013182.","DOI":"10.1016\/j.neuro.2019.02.008"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Hanahisa Y, Yamaguchi M. Characterization of calcium accumulation in the brain of rats administered orally calcium: the significance of energy-dependent mechanism. Mol Cell Biochem.  1996;  158: 1\u20137.","DOI":"10.1007\/BF00225876"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. McGinnis KM, Wang KKW, Gnegy ME. Alterations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells. J Neurochem.  1999;  72: 1853\u20131863.","DOI":"10.1046\/j.1471-4159.1999.0721853.x"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Clemens TL, McGlade SA, Garrett KP, Craviso GL, Hendy GN. Extracellular calcium modulates vitamin D-dependent calbindin-D28K gene expression in chick kidney cells. Endocrinology.  1989;  124: 1582\u20131584.","DOI":"10.1210\/endo-124-3-1582"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Nath S, Goodwin J, Engelborghs Y, Pountney DL. Raised calcium promotes \u03b1-synuclein aggregate formation. Mol Cell Neurosci.  2011;  46: 516\u2013526.","DOI":"10.1016\/j.mcn.2010.12.004"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Freeman AS, Meltzer LT, Bunney BS. Firing properties of substantia nigra dopaminergic neurons in freely moving rats. Life Sci.  1985;  36: 1983\u20131994.","DOI":"10.1016\/0024-3205(85)90448-5"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol.  1988;  395: 233\u2013253.","DOI":"10.1113\/jphysiol.1988.sp016916"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Song Y, Kato S, Fleet JC. Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr.  2003;  133: 374\u2013380.","DOI":"10.1093\/jn\/133.2.374"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Meredith GE, Rademacher DJ. MPTP mouse models of Parkinson\u2019s disease: an update. J Parkinsons Dis.  2011;  1: 19\u201333.","DOI":"10.3233\/JPD-2011-11023"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Barata-Antunes S, Teixeira FG, Mendes-Pinheiro B, Domingues AV, Vila\u00e7a-Faria H, Marote A, et al.\u3000Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson\u2019s Disease. Int J Mol Sci.  2020;  21: 3459.","DOI":"10.3390\/ijms21103459"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/71\/3\/71_22-0011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T05:07:56Z","timestamp":1659762476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/71\/3\/71_22-0011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.22-0011","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22-0011"}}